On November 18, 2024, Novo Nordisk A/S reported that Executive Vice President David Moore purchased 2,500 ADRs at DKK 709.25 each, totaling DKK 1,773,118.70. This trade aligns with regulations for disclosures by board members and executives regarding their share transactions.